BEIJING, Feb. 6, 2026 -- Chinese President Xi Jinping held separate talks with Russian President Vladimir Putin and U.S. President Donald Trump on Wednesday, a rare same-day round of diplomacy. CGTN published an article analyzing the priorities of the two high-level exchanges, and examining China's growing role as a stabilizing force in an increasingly volatile global landscape. Chinese President Xi Jinping held back-to-back talks with Russian President Vladimir Putin and U.S. President Donald Trump on Wednesday, a rare same-day round of diplomacy. The same-day interactions, acc
「無敗」vs「不屈」 アテネ(ギリシャ), 2026年2月6日 -- 史上最も成功し、「無敗」の誉れ高いボクサーFloyd "Money" Mayweather Jr.が、近代五輪発祥の地にしてあらゆるスポーツの原点であるアテネのリングに上がります。 2026年6月27日、Mayweatherは世界的なメガイベント「バトル・オブ・ザ・レジェンド(BATTLE OF THE LEGENDS)」の主役を務め、ギリシャ最高と称される格闘技選手、Mike "Iron" Zambidisと、大陸、時代、格闘技文化の架け橋となる一世一代のスーパーファイトで対戦します。 Mayweatherは50戦無敗という偉大な記録を持ち、スーパーフェザー級からライトミドル級まで5階級にまたがる15の主要なタイトルを制覇しただけでなく、オリンピックの銅メダリストでもある米国のプロボクサーであり、圧倒的な強さ、正確さ、そして息の長い活躍によって知られる、ボクシング界最高の防御技術を誇るボクサー。Mayweatherのパンチはプロボクサーの中で最も正確なパンチを繰り出す。 対戦するのは、ボクシングとキックボクシングにおけるギリシャのレジェンド、Mike "
HONG KONG, Feb. 6, 2026 -- Akeso, Inc. (9926.HK) is pleased to announce that ivonescimab, its global first-in-class bispecific antibody targeting PD-1 and VEGF, has been granted its fifth Breakthrough Therapy Designation from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA). This latest designation applies to ivonescimab in combination with chemotherapy for the first-line treatment of advanced biliary tract cancer (BTC). This milestone represents the fifth BTD awarded to ivonescimab by the NMPA, following three prior designations in lung cance
Since announcing its Corporate Value-Up Plan in 2025, Coway has been seeing tangible progress across revenue growth, shareholder returns, financial soundness and governance To date, the company has executed KRW 247.3 billion in shareholder returns, achieving the 40% return rate goal Starting in FY2026, Coway will prioritize cash dividends to secure high-dividend company status and tax benefits for shareholders Reporting an enhanced compliance rate on key governance indicators of 74%, Coway targets 93% by 2027 SEOUL, South Korea, Feb. 6, 2026 -- Coway Co., Ltd., the &
- Secures distribution agreement to launch CART BP pro in the Japanese hospital and clinic market- Leveraging proven technology with adoptions in 1,700+ medical institutions and national health insurance coverage in Korea SEOUL, South Korea, Feb. 6, 2026 -- Sky Labs Inc. (CEO Jack Byunghwan Lee) announced on the 5th that it has entered into an exclusive distribution agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) for the ring-type blood pressure monitor, 'CART BP pro', in the Japanese hospital and clinic market. This agreement follows the memorandum
Singapore Office Expands APAC Presence to Seven Locations, Delivering Enhanced Local Expertise and Global Scale BETHESDA, Md., Feb. 6, 2026 -- Precision for Medicine (Precision), a global leader in biomarker-driven clinical research and development, has announced the opening of a new office in Singapore. This strategic expansion strengthens Precision's significant presence across the Asia-Pacific (APAC) region, serving as a crucial hub for enhanced client support and accelerated regional growth. "This expansion, particularly with our new Singapore hub, signifies a m
[ 메디채널 황정호 기자 ] With 11 years at the company, Abreu will also serve as CEO of EBANX Singapore, leading regulatory engagement and strengthening ties with APAC merchants CURITIBA, Brazil and SINGAPORE, Feb. 6, 2026 -- EBANX, a global technology company specializing in payment services for emerging markets, today announced the appointment of Eduardo de Abreu as its new Chief Product Officer (CPO). Formerly Vice President of Product based in Brazil, Abreu will relocate to Singapore to lead EBANX's global product roadmap as the company strengthens its presence in the APAC region. &
HONG KONG, Feb. 6, 2026 -- Poised to Fill the Global Market Gap, the Serum-Free Iterative Rabies Vaccine Approaches a Critical Milestone in Commercialization. AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on February 5 that its wholly-owned subsidiary AIM Rongyu's world's first independently developed serum-free iterative rabies vaccine has successfully passed the National Medical Products Administration (NMPA) on-site inspection for drug clinical trials and the on-site inspection for drug registration and production. This marks a major step forward for this highly ant
Love looks like care. This Valentine's Day, VARON invites families to show love in a way that helps loved ones breathe easier—at home and on the go. NEW YORK, Feb. 6, 2026 -- VARON, a trusted provider of respiratory care solutions, today announced its Valentine's Day Sale, a limited-time event designed to celebrate love through meaningful, health-forward gifts. Centered on comfort, mobility, and peace of mind, the event offers thoughtful savings across VARON's lineup of portable oxygen concentrator and home oxygen concentrator options without losing sight of what matters most:
MANILA, Philippines, Feb. 5, 2026 -- Valentine's Day is traditionally associated with flowers and chocolates, but health experts encourage Filipinos to also prioritize well-being for themselves and their loved ones. Respiratory health is increasingly important as more people manage chronic conditions, recover from illness, or maintain active lifestyles amid environmental challenges. VARON Philippines marks the occasion by promoting oxygen care as a meaningful way to show love, emphasizing mobility, comfort, and peace of mind. Love and Health: Caring Beyond